The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease

By the same authors

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease (Review)
Mikocka-Walus, A. A., Prady, S. L., Pollok, J., Esterman, A., Gordon, A., Knowles, S. & Andrews, J., 12 Apr 2019
Article in Cochrane Database of Systematic Reviews
What do participants of the Crohn's and Colitis UK (CCUK) annual York Walk think of their inflammatory bowel disease care? A short report on a survey
The CCUK York Walk Committee, Jan 2018
Article in Gastroenterology Nursing
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease (Protocol)
Mikocka-Walus, A. A., Fielder, A., Prady, S. L., Esterman, A., Knowles, S. & Andrews, J. M., 6 Jul 2017
Article in Cochrane Database of Systematic Reviews
Antidepressants in Inflammatory Bowel Disease: A systematic review
Macer, B., Prady, S. L. & Mikocka-Walus, A. A., 9 Mar 2017
Article in Inflammatory bowel diseases
Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms
McCallum, S., Andrews, J., Gaughwin, M., Turnbull, D. & Mikocka-Walus, A. A., 8 Aug 2016
Article in Patient Preference and Adherence

From the same journal

Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort: Online Psychological Interventions for Mental and Physical Health Outcomes in Gastrointestinal Disorders Including Irritable Bowel Syndrome and Inflammatory Bowel Disease
Hanlon, I., Hewitt, C. E., Bell, K. J., Phillips, A. & Mikocka-Walus, A., 14 Jun 2018
Article in Alimentary pharmacology & therapeutics
Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals
Faria, R., Woods, B., Griffin, S., Palmer, S., Sculpher, M. & Ryder, S. D., 16 Sep 2016
Article in Alimentary pharmacology & therapeutics

Research output: Contribution to journal › Article

Published copy (DOI)

10.1111/j.1365-2036.2008.03754.x

Author(s)

A A Mikocka-Walus
D A Turnbull
J M Andrews
N T Moulding
G J Holtmann

Department/unit(s)

Publication details

Journal	Alimentary pharmacology & therapeutics
Date	Published - Aug 2008
Issue number	4
Volume	28
Number of pages	9
Pages (from-to)	475-83
Original language	English

Abstract

Symptoms of functional gastrointestinal disorders (FGIDs) are common in patients with inflammatory bowel disease (IBD). Psychological comorbidities of anxiety and depression are also highly prevalent in IBD.

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

York staff: edit these data

The York Research Database

By the same authors

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease (Review)

What do participants of the Crohn's and Colitis UK (CCUK) annual York Walk think of their inflammatory bowel disease care? A short report on a survey

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease (Protocol)

Antidepressants in Inflammatory Bowel Disease: A systematic review

Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms